Innospec Net Income
| IOSP Stock | USD 86.14 0.17 0.20% |
As of the 10th of February, Innospec retains the Risk Adjusted Performance of 0.1637, market risk adjusted performance of 0.338, and Downside Deviation of 1.15. Innospec technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Innospec Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.0678 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 40.9 M | 58.1 M | |
| Net Income Applicable To Common Shares | 152.9 M | 160.6 M | |
| Net Income From Continuing Ops | 40.9 M | 38.9 M | |
| Net Income Per Share | 1.29 | 1.72 | |
| Net Income Per E B T | 0.78 | 0.54 |
Innospec | Net Income | Build AI portfolio with Innospec Stock |
Evaluating Innospec's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Innospec's fundamental strength.
Latest Innospec's Net Income Growth Pattern
Below is the plot of the Net Income of Innospec over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Innospec financial statement analysis. It represents the amount of money remaining after all of Innospec operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Innospec's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Innospec's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 35.6 M | 10 Years Trend |
|
Net Income |
| Timeline |
Innospec Net Income Regression Statistics
| Arithmetic Mean | 78,694,336 | |
| Geometric Mean | 71,920,048 | |
| Coefficient Of Variation | 41.70 | |
| Mean Deviation | 25,617,096 | |
| Median | 77,800,000 | |
| Standard Deviation | 32,813,206 | |
| Sample Variance | 1076.7T | |
| Range | 110.4M | |
| R-Value | 0.01 | |
| Mean Square Error | 1148.4T | |
| R-Squared | 0.000044 | |
| Significance | 0.98 | |
| Slope | 42,867 | |
| Total Sum of Squares | 17227.3T |
Innospec Net Income History
Other Fundumenentals of Innospec
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Innospec Net Income component correlations
Innospec Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Innospec is extremely important. It helps to project a fair market value of Innospec Stock properly, considering its historical fundamentals such as Net Income. Since Innospec's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Innospec's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Innospec's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Specialty Chemicals industry sustain growth momentum? Does Innospec have expansion opportunities? Factors like these will boost the valuation of Innospec. Market participants price Innospec higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Innospec demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.61) | Dividend Share 1.63 | Earnings Share (0.04) | Revenue Per Share | Quarterly Revenue Growth (0) |
Investors evaluate Innospec using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Innospec's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Innospec's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Innospec's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innospec is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Innospec's market price signifies the transaction level at which participants voluntarily complete trades.
Innospec 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Innospec's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Innospec.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Innospec on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Innospec or generate 0.0% return on investment in Innospec over 90 days. Innospec is related to or competes with H B, Hawkins, WD 40, Cabot, Century Aluminum, Perimeter Solutions, and Olin. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of No... More
Innospec Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Innospec's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Innospec upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.15 | |||
| Information Ratio | 0.1324 | |||
| Maximum Drawdown | 7.38 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 3.3 |
Innospec Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innospec's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Innospec's standard deviation. In reality, there are many statistical measures that can use Innospec historical prices to predict the future Innospec's volatility.| Risk Adjusted Performance | 0.1637 | |||
| Jensen Alpha | 0.2089 | |||
| Total Risk Alpha | 0.1215 | |||
| Sortino Ratio | 0.1715 | |||
| Treynor Ratio | 0.328 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innospec's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innospec February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1637 | |||
| Market Risk Adjusted Performance | 0.338 | |||
| Mean Deviation | 1.09 | |||
| Semi Deviation | 0.8411 | |||
| Downside Deviation | 1.15 | |||
| Coefficient Of Variation | 504.33 | |||
| Standard Deviation | 1.49 | |||
| Variance | 2.23 | |||
| Information Ratio | 0.1324 | |||
| Jensen Alpha | 0.2089 | |||
| Total Risk Alpha | 0.1215 | |||
| Sortino Ratio | 0.1715 | |||
| Treynor Ratio | 0.328 | |||
| Maximum Drawdown | 7.38 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 3.3 | |||
| Downside Variance | 1.33 | |||
| Semi Variance | 0.7075 | |||
| Expected Short fall | (1.27) | |||
| Skewness | 0.8048 | |||
| Kurtosis | 0.982 |
Innospec Backtested Returns
Innospec appears to be very steady, given 3 months investment horizon. Innospec holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Innospec, which you can use to evaluate the volatility of the firm. Please utilize Innospec's Risk Adjusted Performance of 0.1637, market risk adjusted performance of 0.338, and Downside Deviation of 1.15 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Innospec holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 0.87, which attests to possible diversification benefits within a given portfolio. Innospec returns are very sensitive to returns on the market. As the market goes up or down, Innospec is expected to follow. Please check Innospec's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Innospec's current trending patterns will revert.
Auto-correlation | 0.70 |
Good predictability
Innospec has good predictability. Overlapping area represents the amount of predictability between Innospec time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Innospec price movement. The serial correlation of 0.7 indicates that around 70.0% of current Innospec price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 7.58 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Innospec Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Innospec reported net income of 35.6 M. This is 395.82% lower than that of the Chemicals sector and 91.58% lower than that of the Materials industry. The net income for all United States stocks is 93.77% higher than that of the company.
Innospec Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innospec's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Innospec could also be used in its relative valuation, which is a method of valuing Innospec by comparing valuation metrics of similar companies.Innospec is currently under evaluation in net income category among its peers.
Innospec ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Innospec's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Innospec's managers, analysts, and investors.Environmental | Governance | Social |
Innospec Institutional Holders
Institutional Holdings refers to the ownership stake in Innospec that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Innospec's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Innospec's value.| Shares | Charles Schwab Investment Management Inc | 2025-06-30 | 356.2 K | Millennium Management Llc | 2025-06-30 | 350 K | Jpmorgan Chase & Co | 2025-06-30 | 321.2 K | Qube Research & Technologies | 2025-06-30 | 306.8 K | Northern Trust Corp | 2025-06-30 | 302.5 K | Nuveen, Llc | 2025-06-30 | 296 K | Bank Of America Corp | 2025-06-30 | 295.5 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 263.8 K | Hhg Plc | 2025-06-30 | 255.4 K | Blackrock Inc | 2025-06-30 | 3.7 M | Vanguard Group Inc | 2025-06-30 | 3.2 M |
Innospec Fundamentals
| Return On Equity | -9.0E-4 | ||||
| Return On Asset | -7.0E-4 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.91 B | ||||
| Shares Outstanding | 24.78 M | ||||
| Shares Owned By Insiders | 1.21 % | ||||
| Shares Owned By Institutions | 98.78 % | ||||
| Number Of Shares Shorted | 359.67 K | ||||
| Price To Earning | 96.38 X | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 1.20 X | ||||
| Revenue | 1.85 B | ||||
| Gross Profit | 501.2 M | ||||
| EBITDA | 224.6 M | ||||
| Net Income | 35.6 M | ||||
| Cash And Equivalents | 71.4 M | ||||
| Cash Per Share | 2.88 X | ||||
| Total Debt | 44.9 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.16 X | ||||
| Book Value Per Share | 52.35 X | ||||
| Cash Flow From Operations | 184.5 M | ||||
| Short Ratio | 1.78 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Price To Earnings To Growth | (2.95) X | ||||
| Target Price | 99.33 | ||||
| Number Of Employees | 2.45 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 2.14 B | ||||
| Total Asset | 1.73 B | ||||
| Retained Earnings | 1.02 B | ||||
| Working Capital | 585.2 M | ||||
| Current Asset | 458.7 M | ||||
| Current Liabilities | 206.1 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.19 % | ||||
| Net Asset | 1.73 B | ||||
| Last Dividend Paid | 1.63 |
About Innospec Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innospec's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innospec using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innospec based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Innospec
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.Moving together with Innospec Stock
Moving against Innospec Stock
| 0.86 | NANO | Nano One Materials | PairCorr |
| 0.78 | UT8 | Uber Technologies | PairCorr |
| 0.77 | J9I0 | 5E ADVANCED MATERIALS | PairCorr |
| 0.62 | NEU | NewMarket Earnings Call Tomorrow | PairCorr |
| 0.54 | LWLG | Lightwave Logic | PairCorr |
The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.
The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.